Three-Statement Breakdown
REVENUE UP
Revenue rose 4.1% year over year to $2.9B, and carried a 8.2% net margin.
REVENUE
+4.1%
2,912
GROSS PROFIT
—
—
NET INCOME
-16.7%
238
EPS (DILUTED)
—
—
| Income statement | TTM 24-09 | TTM 24-12 | TTM 25-03 | TTM 25-06 | TTM 25-09 | TTM 25-12 | TTM 26-04 | vs prior TTM | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,722 | 2,755 | 2,770 | 2,798 | 2,813 | 2,856 | 2,902 | 2,912 | +0.3% | +4.1% | |
| Research & development | (197) | (197) | (200) | (205) | (207) | (216) | (220) | (216) | -2.0% | +5.2% | |
| SG&A | (1,006) | (994) | (983) | (980) | (984) | (992) | (996) | (1,026) | +3.0% | +4.7% | |
| Operating income | 305 | 347 | 375 | 380 | 364 | 357 | 360 | 359 | -0.4% | -5.5% | |
| Interest expense |
NOT DISCLOSED
10-Q
|
— | (96) | (95) | (93) | (91) | (92) | (94) | (94) | +0.1% | +1.0% |
| Income tax | -5 | (33) | (38) | (37) | (39) | (28) | (27) | (23) | -12.6% | -37.2% | |
| Net income | 254 | 270 | 287 | 285 | 237 | 241 | 240 | 238 | -0.9% | -16.7% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-08-11 ↗